Etiology

  • Genetic predisposition with association to HLA antigens
  • Consuming gliadin from grains such as wheat, rye, and barley leads to an autoimmune reaction within the small intestinal wall.

Pathophysiology

  • Trigger: Ingestion of gluten (protein in wheat, barley, rye). Its component, gliadin, is the primary immunogenic particle.
  • Key Immune Steps:
    1. tTG Activity: Gliadin peptides are deamidated by tissue transglutaminase (tTG) in the lamina propria.
    2. Antigen Presentation: APCs (Antigen Presenting Cells) present deamidated gliadin to CD4+ T-cells via HLA-DQ2/DQ8.
    3. Inflammation: Activated T-cells release inflammatory cytokines (e.g., IFN-γ), leading to tissue damage.
    4. Antibody Production: B-cells are stimulated to produce characteristic autoantibodies: Anti-tTG (IgA), Anti-endomysial (IgA), and Anti-DGP.
  • Histologic Damage: Chronic inflammation causes classic findings in the small bowel (duodenum/jejunum).
    • Villous atrophy: Blunting of villi leads to malabsorption.
    • Crypt hyperplasia: Compensatory lengthening of crypts.
    • Intraepithelial lymphocytosis: Increased lymphocytes in the epithelial layer.


Clinical features

Gastrointestinal symptoms

Extraintestinal symptoms and associations

  • Malabsorption symptoms: fatigue, weight loss, vitamin deficiency, iron deficiency anemia, osteoporosis, hypocalcemia
  • In children: failure to thrive, growth failure, delayed puberty, secondary hyperparathyroidism
  • Dermatologic associations: dermatitis herpetiformis
    • Transglutaminases play a role in forming extensively cross-linked proteins (e.g., elastin, coagulation by factor XIII).
  • Neuropsychiatric symptoms: peripheral neuropathies (numbness, burning and tingling of the hands and feet) , headache, ataxia, depression, irritability
  • Commonly associated with autoimmune diseases

Diagnostics


Laboratory studies

  • IgA tissue transglutaminase antibody (tTG IgA): initial test
  • Total IgA
    • Indicated for all patients because of the high prevalence of IgA deficiency in patients with celiac disease (approx. 2–3%)
      • Both celiac disease and selective IgA deficiency have strong associations with specific HLA genes, particularly HLA-DQ2 and HLA-DQ8.
    • If patients have low IgA, perform further IgG-based testing.
  • Deamidated gliadin peptide
    • IgG-based testing: indicated in IgA deficiency or discordant biopsy and serology
      • IgG-tissue transglutaminase (tTG IgG)
      • IgG deamidated gliadin peptide (DGP IgG)
    • IgA-based testing: IgA deamidated gliadin peptide (DGP IgA)
  • Anti-endomysial antibody (EMA): Potential second-line confirmatory test (high-specificity)
  • Celiac disease is not associated with elevated systemic inflammatory markers (eg, C-reactive protein, erythrocyte sedimentation rate), since it’s limited.

Endoscopy

  • EGD with small intestine biopsy (confirmatory test)
    • Intraepithelial lymphocytic infiltration
    • Crypt hyperplasia
    • Villous atrophy

Differential diagnostics


Comparison of Common GI Disorders

FeatureCeliac DiseaseCrohn DiseaseTropical SprueLactose IntoleranceIrritable Bowel Syndrome (IBS)
PathoAutoimmune vs. Gliadin (HLA-DQ2/8)Transmural inflammation (Th1 mediated)Post-infectious; affects entire small bowelLactase enzyme deficiencyGut-brain axis d/o; visceral hypersensitivity
LocationProximal Small Bowel (Duodenum)Anywhere (“mouth to anus”); Terminal Ileum commonEntire Small BowelSmall Intestine Brush BorderColon (Function, not structure)
BiopsyVillous atrophy, crypt hyperplasiaNon-caseating granulomas, transmural inflammationVillous atrophy (less severe)NormalNormal
KeyDxAnti-tTG Ab; Dermatitis herpetiformisSkip lesions, “cobblestoning”, fistulasHx of travel to tropics; Folate/B12 def.H₂ breath test; symptoms with dairyPain relieved by defecation; Dx of exclusion
TxGluten-free dietAnti-TNF, Corticosteroids, 5-ASAAntibiotics, Folic AcidAvoid dairy; lactase pillsLow FODMAP diet, fiber, symptom control
Link to original

Tropical sprue

  • Definition: A disease characterized by chronic diarrhea with subsequent malabsorption in association with a stay in the tropics or subtropics.
  • Epidemiology: occurs in residents of the tropics and subtropics or in travelers returning from these areas (after trips lasting several weeks)
  • Etiology: exact cause not known; most likely due to bacterial infection that leads to structural damage of the intestinal mucosa
  • Clinical features: similar to Celiac disease
  • Diagnostics
    • Endoscopy of the small bowel and biopsy: villous atrophy, elongated crypts, presence of inflammatory cells (plasma cells, lymphocytes, eosinophils)
  • Treatment: tetracycline in combination with folic acid for 3–6 months

Treatment


  • Strict, lifelong gluten-free diet
    • Abstain from products containing wheat, rye, barley, or spelt.
    • Symptoms usually improve quickly